Roche | WRoche’s Virtual Early Drug Development pRED Event 2019

Roche’s Virtual Early Drug Development pRED Event 2019

Agenda:

Welcome

Overview and introduction to Roche pRED

Oncology

Neuroscience

Ophthalmology

Q&A

Karl Mahler, Head of Investor Relations

William Pao, Head of Roche Pharma Research and Early Development

Christian Rommel, Global Head of pRED Oncology

Azad Bonni, Global Head of pRED Neuroscience and Rare Diseases

Sascha Fauser, Global Head of pRED Ophthalmology

Please register to access the replay*

First Name

Last name

Corporate Email

Company Name

Confirm you are a human *

Roche has hosted a live video webcast and conference call on Monday, 11 November 2019.

Investors

Downloads

PDF